148 results
8-K
EX-4.1
KPTI
Karyopharm Therapeutics Inc
14 May 24
Other Events
4:06pm
disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software … , without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts
8-K
EX-99.1
KPTI
Karyopharm Therapeutics Inc
8 May 24
Entry into a Material Definitive Agreement
7:52am
Exhibit 99.1
Targeting Disease at the Nuclear Pore
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement … at the Nuclear Pore
New $100.0 Million Senior Secured Term Loan
On May 8, 2024 (the Term Loan Closing Date), the Company also entered into a new $100.0
8-K
EX-99.1
KPTI
Karyopharm Therapeutics Inc
8 May 24
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
7:47am
Exhibit 99.1
Targeting Disease at the Nuclear Pore
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress … at the Nuclear Pore
Effective January 1, 2024, XPOVIO was added to Mainland China’s National Reimbursement Drug List for the treatment of adult patients
8-K
EX-99.1
bt7he ehtkg48
29 Feb 24
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
7:35am
8-K
EX-99.1
04wrynf0v
8 Jan 24
Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives
8:40am
8-K
EX-99.1
flmbrzgfb2o8rn6 zru
2 Nov 23
Karyopharm Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-99.1
j77r99vpjc7lm
2 Aug 23
Karyopharm Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
7:37am
8-K
EX-99.1
lx3ttxy6
4 May 23
Karyopharm Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
7:53am
8-K
EX-99.1
nzbmnxs 2k
5 Dec 22
Karyopharm Announces $165 Million Private Placement
8:41am
8-K
EX-99.1
i8qvy
3 Nov 22
Karyopharm Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
4:11pm